News
In this video, Jay Chhablani, MD, director of clinical research at the UPMC Vision Institute, professor of ophthalmology and ...
ATSN-201 was given regenerative medicine advanced therapy designation to treat X-linked retinoschisis, for which there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback